RegulatoryMay 15, 2026, 07:32 AM
Profusa Moves to Nasdaq Capital Market for Compliance
AI Summary
Profusa, Inc. announced its listing on The Nasdaq Capital Market, effective May 15, 2026. This move represents the first in a series of interim milestones established by the Nasdaq Hearings Panel. The purpose of these steps is to ensure Profusa's continued compliance with Nasdaq's bid price and stockholders' equity requirements for maintaining its listing on the Capital Market tier.
Key Highlights
- Profusa is now listed on The Nasdaq Capital Market, effective May 15, 2026.
- This move is the first of a series of interim milestones set by the Nasdaq Hearings Panel.
- The milestones aim to ensure continued compliance with Nasdaq's bid price requirements.
- The company also seeks to meet stockholders' equity requirements for continued listing.
- Profusa is a digital health company pioneering continuous monitoring of an individual's biochemistry.
Price Impact
More from PFSA